NO175134C - Fremgangsmåte for fremstilling av et frysetörket injeksjonspreparat av (7S,9S)-9-acetyl-9-amino-7-[(2-deoksy- tro-pentopyranosyl)oksyÅ-7,8,9,10-tetrahydro-6,11-dihydroksy-naftacen-5,12-dion eller salter derav - Google Patents

Fremgangsmåte for fremstilling av et frysetörket injeksjonspreparat av (7S,9S)-9-acetyl-9-amino-7-[(2-deoksy- tro-pentopyranosyl)oksyÅ-7,8,9,10-tetrahydro-6,11-dihydroksy-naftacen-5,12-dion eller salter derav

Info

Publication number
NO175134C
NO175134C NO883447A NO883447A NO175134C NO 175134 C NO175134 C NO 175134C NO 883447 A NO883447 A NO 883447A NO 883447 A NO883447 A NO 883447A NO 175134 C NO175134 C NO 175134C
Authority
NO
Norway
Prior art keywords
preparation
salts
pentopyranosyl
naphthacene
dione
Prior art date
Application number
NO883447A
Other languages
English (en)
Norwegian (no)
Other versions
NO883447L (no
NO883447D0 (no
NO175134B (no
Inventor
Yasuhisa Sakamaki
Yukio Ozaki
Norihiko Tanno
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Publication of NO883447D0 publication Critical patent/NO883447D0/no
Publication of NO883447L publication Critical patent/NO883447L/no
Publication of NO175134B publication Critical patent/NO175134B/no
Publication of NO175134C publication Critical patent/NO175134C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO883447A 1987-08-05 1988-08-03 Fremgangsmåte for fremstilling av et frysetörket injeksjonspreparat av (7S,9S)-9-acetyl-9-amino-7-[(2-deoksy- tro-pentopyranosyl)oksyÅ-7,8,9,10-tetrahydro-6,11-dihydroksy-naftacen-5,12-dion eller salter derav NO175134C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62197032A JP2603480B2 (ja) 1987-08-05 1987-08-05 安定化されたアンスラサイクリン系製剤

Publications (4)

Publication Number Publication Date
NO883447D0 NO883447D0 (no) 1988-08-03
NO883447L NO883447L (no) 1989-02-06
NO175134B NO175134B (no) 1994-05-30
NO175134C true NO175134C (no) 1994-09-07

Family

ID=16367605

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883447A NO175134C (no) 1987-08-05 1988-08-03 Fremgangsmåte for fremstilling av et frysetörket injeksjonspreparat av (7S,9S)-9-acetyl-9-amino-7-[(2-deoksy- tro-pentopyranosyl)oksyÅ-7,8,9,10-tetrahydro-6,11-dihydroksy-naftacen-5,12-dion eller salter derav

Country Status (14)

Country Link
US (1) US4952566A (fr)
EP (1) EP0302729B1 (fr)
JP (1) JP2603480B2 (fr)
KR (1) KR970000507B1 (fr)
AT (1) ATE71526T1 (fr)
AU (1) AU609168B2 (fr)
CA (1) CA1324959C (fr)
DE (1) DE3867751D1 (fr)
DK (1) DK173317B1 (fr)
ES (1) ES2038763T3 (fr)
FI (1) FI91483C (fr)
GR (1) GR3004330T3 (fr)
NO (1) NO175134C (fr)
NZ (1) NZ225654A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222489B1 (hu) * 1990-07-25 2003-07-28 Novartis Ag. Stabilizált gyógyszerkészítmények és eljárás az előállításukra
US6300361B1 (en) 1990-07-25 2001-10-09 Novartis Ag Stabilized pharmaceutical compositions comprising acid donors
FR2665834B1 (fr) * 1991-07-24 2001-02-23 Sandoz Sa Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique, et sa preparation.
DE19741715A1 (de) * 1997-09-22 1999-03-25 Hoechst Ag Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
AU1259899A (en) * 1997-11-28 1999-06-16 Sumitomo Pharmaceuticals Company, Limited Crystalline amrubicin hydrochloride
EP1439185A4 (fr) 2001-10-23 2009-08-19 Sumitomo Chemical Co Stabilisation d'hydrochlorure d'amrubicine
CN1741804A (zh) * 2002-11-29 2006-03-01 住友制药株式会社 稳定的蒽环类化合物的冻干制剂
CN100395255C (zh) * 2005-02-02 2008-06-18 江苏豪森药业股份有限公司 马来酸氨柔比星盐及其制备方法和用途
EP1814525A2 (fr) * 2005-05-11 2007-08-08 Sicor Inc. Glycosides d'anthracycline lyophylises stables
ES2524700T3 (es) * 2009-05-27 2014-12-11 Sumitomo Dainippon Pharma Co., Ltd. Formulación estabilizada y liofilizada de compuestos de antraciclina
JP6348509B2 (ja) * 2012-12-19 2018-06-27 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ システインによる亜鉛アミノ酸ハロゲン化物錯体
WO2016024369A1 (fr) * 2014-08-13 2016-02-18 テバ製薬株式会社 Composition médicinale pour le traitement du cancer
WO2019094819A2 (fr) * 2017-11-09 2019-05-16 Abon Pharmaceuticals, Llc Systèmes d'administration par voie intraveineuse pour médicaments de chimiothérapie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2522187C2 (de) * 1975-05-17 1977-10-28 Byk Gulden Lomberg Chem Fab Verwendung von Cystein oder dessen Säureadditionssalz und Natriumdisulfit zur Stabilisierung von injizierbaren, einen pH-Wert zwischen 7 und 9 aufweisenden, Vitamin B tief 12 und nichtsteroidal Entzündungshemmer enthaltenden Arzneimitteln
US4540695A (en) * 1981-08-12 1985-09-10 Sumitomo Chemical Co., Ltd. Aminonaphthacene derivatives and their use
JPS5976099A (ja) * 1982-10-22 1984-04-28 Sumitomo Chem Co Ltd アミノナフタセン誘導体とその製造方法
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions

Also Published As

Publication number Publication date
NO883447L (no) 1989-02-06
FI91483B (fi) 1994-03-31
FI883602A (fi) 1989-02-06
JP2603480B2 (ja) 1997-04-23
ES2038763T3 (es) 1993-08-01
NZ225654A (en) 1991-03-26
DK436688D0 (da) 1988-08-04
NO883447D0 (no) 1988-08-03
KR970000507B1 (ko) 1997-01-13
US4952566A (en) 1990-08-28
GR3004330T3 (fr) 1993-03-31
KR890003791A (ko) 1989-04-18
FI883602A0 (fi) 1988-08-01
DK173317B1 (da) 2000-07-17
AU2042188A (en) 1989-02-09
CA1324959C (fr) 1993-12-07
JPS6440493A (en) 1989-02-10
FI91483C (fi) 1994-07-11
DK436688A (da) 1989-02-06
EP0302729A1 (fr) 1989-02-08
DE3867751D1 (de) 1992-02-27
ATE71526T1 (de) 1992-02-15
EP0302729B1 (fr) 1992-01-15
AU609168B2 (en) 1991-04-26
NO175134B (no) 1994-05-30

Similar Documents

Publication Publication Date Title
NO175134C (no) Fremgangsmåte for fremstilling av et frysetörket injeksjonspreparat av (7S,9S)-9-acetyl-9-amino-7-[(2-deoksy- tro-pentopyranosyl)oksyÅ-7,8,9,10-tetrahydro-6,11-dihydroksy-naftacen-5,12-dion eller salter derav
FR2629819B1 (fr) Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
PT88448A (pt) Process for preparing antiprotozoal pharmaceutical compositionscontaining azithromycin or a derivative thereof
NO941726D0 (no) Fremgangsmåte for fremstilling av 4-amino-1-hydroxy-butyliden-1,2-bisfosfonsyre
FR2629818B1 (fr) Procede de preparation du taxol
DK0382173T3 (da) Substans PF 1022, fremgangsmåde til fremstilling heraf og anthelmintisk præparat indeholdende denne
PT81656B (pt) Processo para a preparacao de polissacarideos bacterianos neutros covalentemente modificados, e de conjugados covalentes estaveis desses polissacarideos e de proteinas imunogenicas
FI915376A (fi) Smakaemnespreparat.
FI890068A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2-bis(aminometyyli)syklobutaani-platinakompleksien valmistamiseksi
DE69002817D1 (de) Vakzine.
SE441598B (sv) Forfarande for framstellning av 16-ledade makrolida antibiotika och syraadditionssalter derav, omfattande nya derivat av tylosin, angolamycin och spiramycin
SE8008181L (sv) Linkomycin och clindamycinanaloger
FI945626A0 (fi) Menetelmä 2,2-difluoriketeenisilyyliasetaalien ja alfa, alfa-difluori-beta-silyylioksi-1,3-dioksolaani-4-propaanihappoestereiden valmistamiseksi
EP0254369A3 (en) Branched polycarbonates containing aliphatic policarboxylic acids or derivatives thereof, and process for their preparation
ATE87926T1 (de) Ethylierte avermectine.
ES2059882T3 (es) Preparacion de la sustancia fr 115224 para administracion parenteral.
DE68911067D1 (de) Platin-(II)-diamin-Komplex, Verfahren zur Herstellung dieser Verbindung, Zusammensetzung mit Antitumorwirkung, die mindestens eine Platin-Verbindung enthält, und geformte Zusammensetzung mit Antitumorwirkung.
ES2080719T3 (es) El operon gal de streptomyces.
ES2036602T3 (es) Un procedimiento de preparacion de 4'-desoxi-13(s)-dihidro-4'-yododoxorubicina.
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
ES2053697T3 (es) Dactilociclina a y dactilociclina b.

Legal Events

Date Code Title Description
MK1K Patent expired